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Abstract
Background: The insular cortex (IC) receives somatosensory afferent input and has been related to nociceptive
input. It has dopaminergic terminals and D1 (D1R) -excitatory- and D2 (D2R) -inhibitory- receptors. D2R activation
with a selective agonist, as well as D1R blockade with antagonists in the IC, diminish neuropathic nociception in a
nerve transection model. An intraplantar injection of carrageenan and acute thermonociception (plantar test) were
performed to measure the response to inflammation (paw withdrawal latency, PWL). Simultaneously, a freely
moving microdyalisis technique and HPLC were used to measure the release of dopamine and its metabolites in
the IC. Plantar test was applied prior, one and three hours after inflammation. Also, mRNA levels of D1 and D2R’s
were measured in the IC after three hours of inflammation.
Results: The results showed a gradual decrease in the release of dopamine, Dopac and HVA after inflammation.
The decrease correlates with a decrease in PWL. D2R’s increased their mRNA expression compared to the controls.
In regard of D1R’s, there was a decrease in their mRNA levels compared to the controls.
Conclusions: Our results showed that the decreased extracellular levels of dopamine induced by inflammation
correlated with the level of pain-related behaviour. These results also showed the increase in dopaminergic
mediated inhibition by an increase in D2R’s and a decrease in D1R’s mRNA. There is a possible differential
mechanism regarding the regulation of excitatory and inhibitory dopaminergic receptors triggered by
inflammation.
Background
The involvement of dopamine in the supraspinal modu-
lation of pain processes has been widely described [1,2].
This evidence was first provided, in the clinical field, by
patients with Parkinson’s disease who among other
symptoms experience an altered pain perception [3].
Also, patients with diabetic polyneuropathy who had
administration of L-dopa showed a decrease in pain [4].
Moreover, the role of dopamine D2 receptors became
evident in the striatal binding capacity associated with
response to cold pain [5].
Analogous to human research, evidence from animal
studies indicates that the supraspinal dopaminergic
system is widely involved in pain processing. Thus, the
dopaminergic neurones in the nucleus accumbens are
related with the suppression of tonic pain [6]. Further-
more, the electrical stimulation of the ventral tegmental
area, which is a dopaminergic nucleus that projects to
several pain matrix structures, diminishes pain related
behaviour [7-9]. Also, the local administration of dopa-
mine or its agonists in pain matrix structures such as
the striatum, nucleus accumbens, anterior cingulate,
ventrolateral orbitofrontal and insular cortices
diminishes pain related behaviours [10-15].
The insular cortex (IC) as a component of the limbic
system and the pain matrix is involved in the dopami-
nergic modulation of nociception. The use of a dopa-
mine uptake inhibitor in the IC increases the
thermonociceptive threshold [14]. Also, there are dopa-
mine D1 and D2 receptors in the IC [16,17]. D2
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receptor activation and D1 blockade diminish neuro-
pathic pain related behaviour [18]. This suggests that
there is a differential modulation of dopaminergic recep-
tors in the IC in relation to chronic nociceptive
processes.
Given the relationship between dopamine, its recep-
tors and nociceptive modulation in the IC, we decided
to measure the release of dopamine and its metabolites
(DOPAC and HVA) as well as dopamine D1 and D2
receptors’ mRNA expression. Both measurements were
done in the IC during the development of an inflamma-
tory pain model in the rat.
Results
Dopamine release in the insular cortex
In this experiment we measured extracellular dopamine
release in the IC during an inflammatory process
induced by the intraplantar injection of carrageenan.
Simultaneously, the behavioural thermonociceptive
response (paw withdrawal latency, PWL, to thermal
nociceptive stimulation) was measured prior to inflam-
mation, as well as one and three hours afterwards.
The release of dopamine and its metabolites in the
inflammation group was decreased when compared to
control and thermonociception groups. This decrease
was of 28.6% 1 h after the induction of inflammation
with carrageenan (p < 0.05) and 63.2% after 3 h for
dopamine (p < 0.05). Regarding DOPAC’s, it decreased
29.4% at 1 h (p < 0.05) and 61.4% at 3 h (p < 0.001).
Similarly, HVA lowered its value 25.2% at 1 h (p < 0.05)
and 65% at 3 h (p < 0.05; Figure 1).
In regard of PWL in this experiment, there was a
decrease of 27% at 1 h (t = -2.335, P = 0.035) and 74.7%
at 3 h (t = -9.938, P < 0.001) after inflammation in the
inflammation group compared with control and thermo-
nociception groups (Figure 2).
Moreover, there was a positive correlation between the
decrease in dopamine, DOPAC and HVA release in the
IC with the decrease in PWL in the inflammation
groups (Pearson correlation: dopamine r = 0.862, p <
0.001; DOPAC r = 0.873, p < 0.001; HVA r = 0.818, p <
0.001) (Figure 3).
mRNA levels of dopamine D1 and D2 receptors in the IC
This experiment evaluated if the same inflammatory pro-
cess as above could produce changes in the expression of
dopamine D1 and D2 receptors’ mRNA levels in the IC.
Dopamine D1 receptor mRNA showed a decrease of
28% (t = -11.167, P = <0.001) in the inflammation group
compared to the control. As opposed to this result,
mRNA levels of D2R were increased in the inflamma-
tion group by 88% (t = -22.468, P < 0.001) (Figure 4).
Discussion
The insular cortex is a well known locus of somatosen-
sory input convergence in humans. Functional imaging
studies consistently show that it is activated after noci-
ceptive input and that it is involved in cognitive and
affective component related with empathy and anticipa-
tion of pain [19-24]. Similar evidence is also available in
the rat, in which painful stimulation activates the
equivalent structure to the human insular cortex
[25-28].
This study highlights the dopaminergic processes
involved in the modulation of peripheral inflammatory
pain in the insular cortex. The results showed that
extracellular level of dopamine decrease and D2 recep-
tor mRNA levels increase, both correlating with a
decrease in paw withdrawal latency. Interestingly, dopa-
mine levels do not vary after repetitive acute thermono-
ciception. This suggests the role played by the insular
cortex in long lasting pain processes. These processes
are subject of being modulated in supraspinal structures
rather than acute ones which are mainly integrated in
the spinal cord [29].
In contrast, Gao and colleagues [30] found that dopa-
mine levels increase in the striatum, periaqueductal grey
and spinal dorsal horn after subjecting animals to the
same model of nociception. Regarding the results found
in the IC, it is a pro-nociceptive locus which when sti-
mulated with dopaminergic agonists produces a decrease
in pain related behaviours [14,18]. Therefore, since it
ought to be activated after nociceptive input, physiologi-
cal release of dopamine would need to be reduced. Neu-
roanatomical evidence that supports this suggestion is
given by the evidence in which a lesion is performed in
the IC. After the animals were subjected to several noci-
ceptive tests, all the behaviours were diminished [31].
Moreover, if dopamine D1 receptors are blocked in the
IC, chronic pain related behaviour is also decreased [18].
The insular cortex expresses a higher quantity of exci-
tatory dopamine D1 receptors [16,17]. Therefore, in this
work a double compensatory mechanism becomes evi-
dent. On the one hand, there is a decrease in dopamine
release and D1 receptors’ mRNA levels and on the
other, an increase in inhibitory dopamine D2 receptors’
expression. Interestingly, both of the aforementioned
results correlate with the level of nociceptive behaviour
which we measured as PWL. Similar findings were
described in the anterior cingulate cortex with the
expression of mRNA of dopaminergic D1 and D2 recep-
tors [32]. This suggests an important receptor dynamic
in which there is regulation and crosstalk between exci-
tatory and inhibitory receptors in several limbic struc-
tures related to pain modulation.
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Figure 1 The graphs show extracellular levels of (A) dopamine, (B) DOPAC and (C) HVA in the insular cortex. The data are expressed as
the percentage of their respective basal levels. Notice that group with inflammation (which received an intraplantar injection of carrageenan)
shows a decreased percentage in the levels of dopamine and its metabolites when compared with the control and thermonociception groups.
Repeated measures ANOVA, Dopamine (F = 7.817 p = 0.021, n = 6), DOPAC (F = 11.223 p = 0.002, n = 8) and HVA (F = 6.902 p = 0.006, n = 8).
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Conclusions
This study shows evidence about the cellular and
dynamic neurotransmitter response in a specific site of
the pain matrix after a very frequent event in pain
patients, inflammation.
Material and Methods
The experiments were conducted in agreement with the
ethics committee regulations of the International Asso-
ciation for the Study of Pain [33] and with our institu-
tion project’s and bioethics commission approval.
Male Wistar rats (250-300 g) were raised, housed and
maintained in our institution’s animal house. The ani-
mals were kept in transparent acrylic individual cages,
with light-dark cycles of 12:12 h at 23°C and 52%
humidity, and with ad libitum feeding and hydration.
Dopamine release in the insular cortex
Extracellular concentration of dopamine and its metabo-
lites were measured in the IC by means of microdialysis
in freely moving rats and high performance liquid chro-
matography (HPLC) during the development of an
inflammatory pain model.
Inflammatory induction and thermal stimulation
An inflammatory process was induced by the infiltration in
the right hind paw of carrageenan lambda (Sigma Chemical
Co. St. Louis MO, USA, CAR 1% in saline solution, 250 μl).
Thermonociceptive response was measured in a Plan-
tar Test Apparatus (Ugo Basile mod.7370). Paw withdra-
wal latency (PWL) was determined to the nearest 0.1
second by the electronic clock of the device.
In vivo microdialysis
Rats were anaesthetised with isofluorane 2% mixed with
98% O2 and mounted in a stereotaxic frame. A guide
cannula (CMA-11-Microdialysis, Acton, MA) was
Figure 2 Antialgesic nociceptive response in the inflammation
and thermonociception groups measured as paw withdrawal
latency (PWL) in s after a thermonociceptive stimulus. The
figure shows PWL before the induction of inflammation with
carrageenan 1% (250 μl) in the inflammation group in the first set
of bars. The second and third sets of bars show PWL 1 h and 3 h
after inflammation, respectively. The thermonociception groups did
not have inflammation induced and were tested in parallel with the
inflammation group. Notice that the inflammation group has no
difference in PWL before inflammation compared to the
thermonociception group and shows a progressively decreased
PWL 1 h (t = -2.335, p = 0.035) and 3 h (t = -9.938, p < 0.001)
thereafter.
Figure 3 The figure represents a positive correlation between
paw withdrawal latency (PWL) and (A) dopamine, (B) DOPAC
or (C) HVA. The dots in orange depict the measurements three
hours after the carrageenan injection, the green ones 1 h afterwards
and the black ones show the status prior to inflammation. Notice
that as the release of dopamine and its metabolites increases, so
does PWL and vice versa (Pearson correlation, dopamine r = 0.862,
p < 0.001; DOPAC r = 0.873, p < 0.001; and HVA r = 0.818, p <
0.001).
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stereotaxically implanted into the insular cortex. Forty
eight hours after cannulation, a microdialysis probe
(SciPro Inc. 12, 2 mm tip length) was inserted into the
guide cannula so that its tip ended in the IC (A = 1
mm from bregma, L = 4.8 mm, H = 5.8 mm from
meninges) using coordinates according to the atlas by
Paxinos and Watson (1998). Each probe was continu-
ously perfused at 2 μl/min with sterile artificial cere-
brospinal fluid (aCSF) (145 mM NaCl, 2.8 mM KCl,
3.0 mM CaCl2, 5.4 mM D-glucose, pH 7.2) using a
microinfusion pump (KD Scientific, Holliston, MA,
USA). Animals were individually housed for the dura-
tion of the experiment in a system for freely-moving
animals and microdialysate samples were collected at
20 min intervals into microvials containing 4 μl of
L-Glutathione 0.08% (Sigma-Aldrich) to reduce oxida-
tion of monoamines.
Biochemical conditions (HPLC)
An isocratic, high-performance liquid chromatography-
electrochemical detection (HPLC-ECD) assay was used
to quantify dopamine, in 20-μl samples of microdialy-
sate. A mobile phase containing, 95% of 12.5 mM citric
acid, 0.07 mM 1-octanesulfonic acid sodium salt, 0.05
mM EDTA and 25 nM ortho phosphoric acid, and 5%
of methanol HPLC (adjusted to pH 3.2 with KOH
10 M), was pumped at 0.1 ml/min through an X Terra
C 18 (2.1 × 50 mm, 3.5 μm ODS) column. Online data
capture was performed using Waters Empower software
for HPLC.
The animals were divided in the following groups:
Control (n = 6): basal extracellular concentration of
dopamine, DOPAC (d-hydroxy-phenyl acetic acid) and
HVA (homovanilic acid) during three hours.
Thermonociception group (n = 6): extracellular con-
centrations of dopamine, DOPAC and HVA were mea-
sured during three hours and plantar test was carried
out at the beginning of the microdialysis, and also one
and three h later.
Inflammation group (n = 6): extracellular concentra-
tions of dopamine, DOPAC and HVA were measured
prior to the induction of inflammation and until three h
after its induction. Plantar test was carried out prior to
inflammation and one and three h afterwards.
Statistically significant differences (p < 0.05) between
groups on extracellular concentrations of dopamine in
the IC, were established by repeated measures ANOVA,
with a post hoc Tukey test.
In order to establish differences in PWL between the
control and each experimental group a Student’s t-test
was performed. Significance was considered with a value
of p < 0.05. A Pearson’s correlation was performed in
order to test if there was a relationship between de
dopamine release and PWL.
Histological verification
At the end of the experiment the correct microdialysis
probe placement was verified. Briefly, the animals were
intracardially perfused with physiological saline solution,
followed by 10% formaldehyde. The brains were allowed
to postfix for 2 days and cut in 40 μm coronal slices
that were immediately placed in a glass slide and digita-
lised in a scanner (HP Scanjet 5550C). The images were
Figure 4 D1 and D2 mRNA levels were semi-quantified by
RT-PCR and related to G3PDH mRNA. Values are the ratio of D1
or D2 cDNA/G3PDH and expressed as the mean ± SEM calculated
as % of control (thermonociception) control values (C = 100%).
Frame (A) shows an increase in dopamine D2 receptor mRNA levels
in the group with inflammation (188 ± 3.2%) with respect to 100%
of the control (p = 0.000). Frame (B) shows a decrease in dopamine
D1 receptor mRNA levels in the group with inflammation (72 ±
1.6%) with respect to the control (100%, p = 0.000). At the top of
each bar, there is an example of the electrophoresis agarose gel
showing the control oligonucleotide (upper band) and the cDNA of
D1R’s in (B) and D2R’s in (A) (lower band).
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analysed by comparing them to an anatomical atlas [34].
(Figure 5)
Dopamine D1 and D2 mRNA levels in the Insular Cortex
In another series of experiments, dopamine D1 and D2
receptor mRNA levels were analysed in the IC after the
induction of an inflammatory process.
Reverse transcriptase polymerase chain reaction (RT-PCR)
procedure
The animals were sacrificed by decapitation and the
brain was extracted and frozen in dry ice (-70°C). In
order to extract the IC (contralateral to inflamed hind
paw), a coronal brain slice was obtained. Then, one
punch with a 1.0 mm diameter sample corer was done
in the IC [34].
Semi-quantification of mRNA by reverse trascriptase
polymerase chain reaction (RT-PCR) was carried out
afterwards. Frozen IC was homogenized in 4 M guani-
dine thyocianate (ICN, Aurora, Ohio, USA) and total
RNA extracted as has previously been described [35].
RNA quality of samples was verified by the ratio of O.D.
absorbencies 260/280 nm and 260/230 nm considered
appropriate when value was >1.8, and by electrophoresis
quantifying 28S/18S ratio and discarded if lower than
1.8 or, when evidence of degradation was observed by
increased staining at the end of the gel. mRNA levels of
D1R and D2R from IC were semi-quantified by reverse-
transcriptase polymerase chain reaction (RT-PCR), using
glyceraldehyde 3-phosphate dehydrogenase (G3PDH)
and actin genes as control transcripts. The protocol
used was essentially as described in [36]: 1.5 μg of RNA
was used to obtain cDNA (M-MLV reverse transcriptase
(Carlsbad, CA, USA) and oligo-dT (Universidad Nacio-
nal Autónoma de México UNAM Biotechnology Insti-
tute’s facilities), followed by the PCR reaction: the
number of cycles for each probe was optimized for each
region to assure linear conditions, using 1 μl and 25
pmol of D1R probe (sense sequence: CAT TCT GAA
CCT CTG CGT GA; antisense: GTT GTC ATC CTC
GGT GTC CT), for D2R using 1 μl and 25 pmol (sense
sequence: CAT TGT CTG GGT CCT GTC CT; anti-
sense: GAC CAG CAG AGT GAC GAT GA); 1 μl and
50 pmol G3PDH (sense sequence: TGA AGG TCG
Figure 5 Histological verification of the microdialysis cannula. (A) Cannula position in three different experiments. The figures show the
guide cannula (red arrow) and membrane trace (black arrow). Notice that the membrane location (black arrow) involves the three regions of the
insular cortex (granular, GI; dysgranular, DI; and agranular, AI). (B) A close up of the left IC was superimposed to an image from the atlas by
Paxinos and Watson (1998) in order to define the location of the microdialysis probe. The piriform cortex (Pi) is in the ventral border of the IC
which corresponds to the AI. The upper limit, corresponding to the GI, is attached to the upper lip region of S1 (S1ULp). The medial border
comprising the three regions of the IC corresponds to the claustrum (Cl).
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GTG TCA ACG GAT TTG GC; antisense: CAT GTA
GGC CAT GAG GTC CAC CAC); and 1 μl and 25
pmol for actin (sense sequence: GAC GAT GCT CCC
CGG GCT GTA TTC; antisense: TCT CTT GCT CTG
GGC CTC GTC ACC) and 0.5 μl Taq DNA polymerase
(5U/μl) (Biotecnologías Universitarias, UNAM, DF,
México). Oligonucleotides were synthesized at the Insti-
tuto de Biotecnología, UNAM. Final conditions for the
IC were: 29 cycles for D1R, 30 for D2R, 20 for G3PDH
and 23 for actin. Each cycle consisted of 95°C for 1 min
followed by: 1 min at 55°C for D1R, D2R and 64°C for
G3PDH and actin; all followed by 1 min 15 s at 72 °C.
All cDNAs had a final extension of 10 min at 72°C. Sev-
eral cDNAs were semiquantified from the same RT
reaction.
PCR products (10 μl of each DNA, and 5 μl of
G3PDH) were separated by 2% of agarose (Ultra-pure
Bio-Rad, Hercules CA, USA) gel electrophoresis, stained
with ethidium bromide (1 mg/L) and density measured
with the Advanced American Biotech Imaging software
(American-Applied Biotechnology, Fullerton, CA, USA).
The relative amounts of the studied cDNAs were calcu-
lated as the ratio of each cDNA over G3PDH and actin
densities. Care was taken to include samples of controls
and experimental groups in the same gel.
There were two groups for this experiment:
Control (n = 8): mRNA was analysed by RT-PCR in
animal without interventions.
Inflammation group (n = 8): mRNA was analysed by
RT-PCR in rats after three hours of the induction of
inflammation.
For the statistical significance between groups a stu-
dent’s t test was used. Significance was considered when
p < 0.05.
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